申请人:THERAVANCE INC
公开号:WO2014025891A1
公开(公告)日:2014-02-13
In one aspect, the invention relates to compounds having the formula (I): where X, Ra, Rb, R2, and R7 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds are prodrugs of compounds having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising these compounds; methods of using these compounds; and processes and intermediates for preparing these compounds.